Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-019-02431-8
Abstract: The safety of anti-programmed cell death 1 (PD-1) antibody for patients with preexisting interstitial lung disease (ILD) remains unknown. The aim of this study was to evaluate the dependence of preexisting ILD on anti-PD-1 antibody-induced…
read more here.
Keywords:
preexisting ild;
anti antibody;
antibody;
patients preexisting ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Medical Oncology"
DOI: 10.1007/s12032-019-1274-0
Abstract: In non-small cell lung cancer (NSCLC) patients, the expression of tumor programmed death ligand 1 (PD-L1) is an important parameter for deciding the timing of the use of anti-programmed cell death 1 (PD-1) antibody. There…
read more here.
Keywords:
preexisting ild;
lung;
patients preexisting;
tumor expression ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2022.2054054
Abstract: Abstract This retrospective study evaluated the safety and efficacy of holmium laser enucleation of the prostate (HoLEP) in patients with an inflatable penile prosthesis (IPP). Five men with a preexisting IPP underwent HoLEP for obstructive…
read more here.
Keywords:
inflatable penile;
holmium laser;
enucleation prostate;
laser enucleation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Transplantation"
DOI: 10.1097/tp.0000000000004402
Abstract: Background. Advances in surgical and medical technology over the years has made liver transplantation possible for older and higher risk patients. Despite rigorous preoperative cardiac testing, cardiovascular events remain a major cause of death after…
read more here.
Keywords:
cad;
transplantation;
preexisting coronary;
coronary artery ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020953501
Abstract: Background Although intravenous (IV) bisphosphonates are first-line medications for the management of hypercalcemia, studies examining their use in patients with preexisting renal dysfunction are limited. Objective The objective of this study is to describe the…
read more here.
Keywords:
renal dysfunction;
hypercalcemia;
preexisting renal;
patients preexisting ... See more keywords